Skip to search.
 TSX Down 1.14% TSX Ventures Down 1.33%

Delcath Systems, Inc. (DCTH)

-NasdaqCM
0.32 Up 0.02(6.63%) May 3, 4:00PM EDT
Prev Close:0.30
Open:0.30
Bid:N/A
Ask:0.55 x 2000
1y Target Est:1.00
Beta:1.05077
Earnings Date:May 4 - May 9 (Est.)
Day's Range:0.30 - 0.33
52wk Range:0.25 - 1.92
Volume:107,340
Avg Vol (3m):131,666
Market Cap:7.69M
P/E (ttm):N/A
EPS (ttm):-0.96
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

Comparison

Symbol% ChgMkt Cap
DCTHUp 6.63%7.69M
LLYDown 0.65%81.06B
PFEUp 2.74%208.67B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):4.08
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :-1.12
Quarterly EPS Est (Mar-16) :-0.19
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):-0.02

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Delcath Systems, Inc. operates as a specialty pharmaceutical and medical device company focusing on cancers of the liver. The company is developing its proprietary product-Melphalan Hydrochloride for injection for use with the Delcath Hepatic Deli... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback